Nanotechnology in Medical Applications: The Global Market

Published - Sep 2015| Analyst - Paul Evers| Code - HLC069C
Nanotechnology in Medical Applications: The Global Market
Single User License: $2,750 Member Price: FREE

Report Highlights

Global nanomedicine market was valued at $214.2 billion in 2013 and $248.3 billion in 2014. The total market is projected to grow at a compound annual growth rate (CAGR) of 16.3% from 2014 through 2019 and reach $528 billion by 2019.

Report Includes

  • An overview of the global markets for nanotechnology used in medical applications.
  • Analyses of global market trends, with data from 2012 to 2014, and projections of CAGRs through 2019.
  • A review of technologies involved, in-depth analysis of applications in practice, and evaluation of future or potential applications.
  • Information on a number of significant products in which the nano dimension has made a significant contribution to product effectiveness.
  • A look at the regulatory environment, healthcare policies, demographics, and other factors that directly affect nanotechnology used in medicine.
  • Analysis of the market's dynamics, specifically growth drivers, inhibitors, and opportunities.
  • Coverage of strategies employed by companies specializing in nanomedicine to meet the challenges of this highly competitive market.

SCOPE OF REPORT

This report discusses the implications of technology and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and as analyzed by selected national markets. The important technologies supporting nanomedicine are reviewed, and the nature and structure of the nanomedicine industry is discussed with profiles of the leading companies, including recent M&A activity. Five-year sales forecasts are provided for the national markets and the major therapeutic categories of products involved.

ANALYST’S CREDENTIALS

Paul Evers has been involved in analyzing pharmaceutical and medical markets for 20 years. He is the author of previous reports on the nanomedicine marketplace as well as analyses of major therapeutic categories and the pharmaceutical regulatory environment.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
 
Published - Jan-2012| Analyst - Paul Evers| Code - HLC069B

Report Highlights

The global nanomedicine market reached $43.2 billion in 2010 and $50.1 billion in 2011. The market is expected to grow to $96.9 billion by 2016 at a compound annual growth rate (CAGR) of 14.1% between years 2011 and 2016.

Published - Jan-2010| Analyst - Paul Evers| Code - HLC069A

Report Highlights

  • The global nanomedicine market was valued at $53 billion in 2009, and is forecast to increase at a compound annual growth rate (CAGR) of 13.5% to reach more than $100 billion in 2014. 
  • Nanomedical products for cancer are one of the largets market segments, worth nearly $20 billion in 2009. This sector is expected to increase at a compound annual growth rate (CAGR) of 11% to reach $33 billion in 2014.
  • Nanomedicine for CNS indications is another major market sector, valued at nearly $11 billion in 2009 and expected to reach $18 billion by 2014, an 11.1% compound annual growth rate (CAGR).

RELATED REPORTS
Share This Report